Challenges in diagnosing cardiac sarcoidosis: should we increase our index of suspicion?
Sarcoidosis is a multisystem disease involving the lungs in up to 90% of cases; however, 30% of patients will have systemic sarcoidosis, including involvement of the heart. Cardiac sarcoidosis can affect any part of the heart and manifest in various ways, with the most common presentations being AV...
Main Author: | Ariana Rose Tagliaferri |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-09-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2020.1796053 |
Similar Items
-
Diagnosis of isolated cardiac sarcoidosis based on new guidelines
by: Hideki Kawai, et al.
Published: (2020-10-01) -
Cardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management
by: Issa Pour-Ghaz, et al.
Published: (2021-05-01) -
Infliximab Treatment of Refractory Cardiac Sarcoidosis
by: Majid Asawaeer, MD, et al.
Published: (2020-08-01) -
Features and clinical impact of extra-cardiac lesions with 18F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis
by: Haruhiko Higashi, et al.
Published: (2020-10-01) -
Cardiac sarcoidosis – Diagnostic challenges due to an unusual clinical presentation
by: Karolis Kluonaitis
Published: (2017-07-01)